← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 22, 2020Last known activity
Aug 15, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT07196358Sponsor investigatorN/AAug 15, 2024
- NCT07196358Lead sponsorN/AAug 15, 2024
- NCT04700228Reponsible party - principal investigatorPhase 4Feb 28, 2021
- NCT04700228Lead sponsorPhase 4Feb 28, 2021
- NCT04646317Lead sponsorEarly Phase 1Dec 30, 2020
- NCT04646317Reponsible party - principal investigatorEarly Phase 1Dec 30, 2020
- NCT04723524CollaboratorPhase 2Sep 22, 2020
Details
- Last known activity
- Aug 15, 2024